Neuland Laboratories Ltd
Ticker: NEULANDLAB
Decent
68/100
☆ Add to Watchlist
Investing Reference
Price
16098.00
Market Cap
20653.56
Debt/Equity
0.1031
ROE %
18.529
PB
13.5450
Promoter %
32.675
Pledge %
0.000
1Y Rev Growth %
0.167
5Y Rev Growth %
15.471
NP Margin %
16.527
NP Margin 5Y Avg %
12.880
Trading Reference
1M Return %
2.565
6M Return %
27.156
1Y Return %
2.902
% Away 52W High
12.436
% Away 52W Low
57.968
Daily Volume
25305
Investment Verdict
Hold
Score 61/100 · Position size: 30%
Fundamentals are OK but not compelling. Maintain current position; avoid fresh adds.
Trading Verdict
Watch
Score 55/100 · Position size: 10%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
100%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.
AI Probability Statement
Probability Statement
Neuland Laboratories Ltd is currently trading near a key support level, with the 50-day EMA indicating a bullish trend. If the stock breaks above the resistance level, there is a potential upside of 15%. However, if it falls below the support level, a downside of 10% could occur.
Upside Probability: 15% | Downside Probability: 10%
Probability estimates are technical-context statements, not investment advice.
More Options
A
Asahi India Glass Ltd
Asahi India Glass Ltd shows potential for growth in a future-ready sector, but faces challenges in profitability and valuation metrics.
View details
A
Ather Energy Ltd
Ather Energy Ltd shows potential in a growing sector, but faces challenges in profitability and valuation. Caution is advised.
View details
M
Maharashtra Scooters Ltd
Maharashtra Scooters Ltd shows moderate potential with some strengths in governance and profitability, but faces challenges in growth consistency and market execution.
View details
P
Poly Medicure Ltd
Poly Medicure Ltd shows potential for growth with a decent financial profile, but investors should be cautious of execution risks and increasing competition.
View details
J
Jyoti CNC Automation Ltd
Jyoti CNC Automation Ltd shows decent potential with consistent growth, but faces challenges in execution and market competition.
View details
K
Karur Vysya Bank Ltd
Karur Vysya Bank shows potential but faces challenges in growth and execution, making it a cautious investment.
View details
J
JSW Cement Ltd
JSW Cement Ltd shows decent potential with consistent growth and a strong market position, but faces valuation concerns and execution risks.
View details
C
Crompton Greaves Consumer Electricals Ltd
Crompton Greaves has a decent growth outlook but faces challenges in profitability and valuation metrics. Investors should be cautious.
View details
H
Hatsun Agro Product Ltd
Hatsun Agro Product Ltd shows potential in a growing sector, but faces challenges in profitability and valuation metrics.
View details
N
Nexus Select Trust
Nexus Select Trust shows potential for growth but faces challenges in profitability and valuation metrics.
View details
M
Mindspace Business Parks REIT
Mindspace Business Parks REIT shows potential for growth but faces challenges in profitability and valuation metrics. It is advisable to monitor closely before making investment decisions.
View details
A
Angel One Ltd
Angel One Ltd shows potential for growth in a competitive sector, but faces challenges in profitability and valuation metrics.
View details
K
Kansai Nerolac Paints Ltd
Kansai Nerolac Paints Ltd shows decent potential with a strong market position, but faces challenges in profitability and valuation metrics.
View details
B
BASF India Ltd
BASF India Ltd shows potential for growth but faces several risks that could impact its performance.
View details
N
Nava Limited
Nava Limited shows potential in a future-ready sector, but faces challenges in growth consistency and profitability metrics.
View details
A
Aditya Birla Real Estate Ltd
Aditya Birla Real Estate Ltd shows several weaknesses in growth, profitability, and market sentiment, indicating a risky investment.
View details
Business Overview
Neuland Laboratories Ltd is a prominent Indian pharmaceutical company specializing in the development and manufacturing of active pharmaceutical ingredients (APIs) and intermediates. Catering to global pharmaceutical firms, Neuland plays a crucial role in the healthcare ecosystem by ensuring quality and compliance in drug production. With a strong focus on innovation and sustainability, the company is well-positioned to meet the growing demand for pharmaceuticals worldwide. Investing in Neuland means supporting a company dedicated to enhancing health outcomes through cutting-edge solutions.
- Established leader in API manufacturing
- Strong global client base
- Commitment to quality and compliance
- Focus on innovation and sustainability
- Robust growth potential in the pharmaceutical sector
Investment Thesis
Neuland Laboratories Ltd presents a compelling investment opportunity due to its credible promoter group, robust growth in digital services, and attractive valuation compared to peers. The company's strategic focus on innovation and expansion positions it well for future growth, making it a strong contender in the pharmaceutical sector.
- Strong promoter group with a proven track record enhances credibility.
- Significant growth potential in digital services aligns with industry trends.
- Attractive valuation compared to peers offers a margin of safety.
- Strategic investments in R&D bolster long-term growth prospects.
- Solid financial performance and consistent dividend payouts add to investor appeal.
Opportunity vs Risk
Opportunities
- Growing demand for pharmaceutical products
- Expansion into international markets
- Strong R&D capabilities
- Strategic partnerships with global firms
Risks ⚠️
- Regulatory changes impacting operations
- Intense competition in the sector
- Dependence on key clients
- Fluctuating raw material costs
Peer Perspective
Neuland Laboratories Ltd trades at a discount to peers like Aarti Industries and Divi's Laboratories, primarily due to margin volatility. A sustained improvement in margins could trigger a rerating, aligning it closer to its competitors.
Future Outlook
Neuland Laboratories Ltd is well-positioned for growth, driven by strong demand in the pharmaceutical sector. However, successful execution of its expansion plans and effective cost control will be crucial to achieving sustainable profitability.
AI FAQs for Retail Users
- Q: What does Neuland Laboratories do?A: Neuland Laboratories specializes in manufacturing active pharmaceutical ingredients and contract research services.
- Q: Is Neuland Laboratories a profitable company?A: The company has shown profitability in recent years, but past performance does not guarantee future results.
- Q: What are the risks of investing in Neuland Laboratories?A: Risks include market volatility, regulatory changes, and competition in the pharmaceutical industry.
- Q: How can I buy shares of Neuland Laboratories?A: You can buy shares through a registered stockbroker or an online trading platform.
- Q: What factors influence Neuland Laboratories' stock price?A: Factors include company performance, industry trends, and overall market conditions.
📊 Stock Investment Checklist (100 Points)
Neuland Laboratories Ltd • Updated: 2025-09-18 09:06:11
-
10BusinessHighPharmaceutical sector is growing, but competition is intense.
-
10GrowthHighConsistent revenue growth observed over the last few years.
-
10ProfitabilityHighROE and ROCE are healthy, but OCF is slightly volatile.
-
8ValuationHighP/E ratio is higher than industry average, indicating overvaluation.
-
7BalanceHighModerate debt levels, liquidity is adequate.
-
6GovernanceGoodPromoter holding is decent, but some pledging exists.
-
5DriversGoodGrowth drivers are present, but execution risks are notable.
-
5TechnicalsGoodMarket sentiment is mixed, with low liquidity.
Final Score & Verdict
Score 68 / 100
• Decent
Neuland Laboratories Ltd shows decent potential with consistent growth, but faces challenges in valuation and execution risks.